Even with these limitations in mind, it is interesting to note that Kaplan–Meier analyses of all available GEPIA2 data revealed that cancers with low MTF2 mRNA levels trend towards poor overall survival rates (Figure 4A). The gene discussed is MTF2; the disease is cancer.